Silvestro, Marcello
Esposito, Fabrizio
De Rosa, Alessandro Pasquale
Orologio, Ilaria
Trojsi, Francesca
Tartaglione, Lorenzo
García-Polo, Pablo
Tedeschi, Gioacchino
Tessitore, Alessandro
Cirillo, Mario
Russo, Antonio
Article History
Received: 3 April 2024
Accepted: 4 October 2024
First Online: 15 October 2024
Declarations
:
: The study was approved by the Ethics Committee of University of Campania “Luigi Vanvitelli” with protocol number 0013971, and written informed consent was obtained from all subjects according to the Declaration of Helsinki.
: Not applicable.
: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article:Dr Silvestro has received speaker honoraria from Novartis, Teva and Lilly.Professor Tessitore has received speaker honoraria from Novartis, Schwarz Pharma/UCB, Lundbeck, Abbvie and Glaxo.Professor Tedeschi has received speaker honoraria from Sanofi-Aventis, Merck Serono, Bayer Schering Pharma, Novartis, Biogen-Dompe´ AG, Teva and Lilly; has received funding for travel from Bayer Schering Pharma, Biogen-Dompe´ AG, Merck Serono, Novartis and Sanofi Aventis; and serves as an associate editor of Neurological Sciences.Professor Russo has received speaker honoraria from Allergan, Lilly, Pfizer, Novartis and Teva and serves as an associate editor of Frontiers in Neurology (Headache Medicine and Facial Pain session).The other authors have nothing to declare.